The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease
Abstract
IMPORTANCE: The dream enactment of rapid eye movement sleep behavior disorder (RBD) is often the first indication of an impending α-synuclein disorder, such as Parkinson disease, multiple-system atrophy, or dementia with Lewy bodies. OBJECTIVE: To provide an overview of RBD from the onset of dream enactment through the emergence of a parkinsonian disorder. EVIDENCE REVIEW: Peer-reviewed articles, including case reports, case series, retrospective reviews, prospective randomized trials, and basic science investigations, were identified in a PubMed search of articles on RBD from January 1, 1986, through July 31, 2014. FINDINGS: Under normal conditions, vivid dream mentation combined with skeletal muscle paralysis characterizes rapid eye movement sleep. In RBD, α-synuclein abnormalities in the brainstem disinhibit rapid eye movement sleep motor activity, leading to dream enactment. The behaviors of RBD are often theatrical, with complexity, aggression, and violence; fighting and fleeing actions can be injurious to patients as well as bed partners. Rapid eye movement sleep behavior disorder is distinguished from other parasomnias by clinical features and the demonstration of rapid eye movement sleep without atonia on polysomnography. Consistent with early neurodegeneration, patients with RBD demonstrate subtle motor, cognitive, and autonomic impairments. Approximately 50% of patients with spontaneous RBD will convert to a parkinsonian disorder within a decade. Ultimately, nearly all (81%-90%) patients with RBD develop a neurodegenerative disorder. Among patients with Parkinson disease, RBD predicts a non-tremor-predominant subtype, gait freezing, and an aggressive clinical course. The most commonly cited RBD treatments include low-dose clonazepam or high-dose melatonin taken orally at bedtime. CONCLUSIONS AND RELEVANCE: Treatment of RBD can prevent injury to patients and bed partners. Because RBD is a prodromal syndrome of Parkinson disease (or related disorder), it represents a unique opportunity for developing and testing disease-modifying therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Sleep Disorders: Diagnostic and Coding Manual
Daroff, R. B. (1991) · Neurology · doi:10.1212/wnl.41.1.160 · Cited by 5,014
Parkinson, J. (2002) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.14.2.223 · Cited by 1,628
Schenck, C. H., Boeve, B. F., & Mahowald, M. W. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2012.10.009 · Cited by 814
Self-citationBoeve, B. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05115.x · Cited by 643
Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients
Iranzo, A., Fernández-Arcos, A., Tolosa, E., Serradell, M., Molinuevo, J. L., Valldeoriola, F., Gelpi, E., Vilaseca, I., Sánchez-Valle, R., Lladó, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089741 · Cited by 548
Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults
Schenck, C. H. (1987) · JAMA · doi:10.1001/jama.257.13.1786 · Cited by 330
Self-citationMild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease
Gagnon, J., Vendette, M., Postuma, R. B., Desjardins, C., Massicotte‐Marquez, J., Panisset, M., & Montplaisir, J. (2009) · Annals of Neurology · doi:10.1002/ana.21680 · Cited by 325
Iranzo, A., Valldeoriola, F., Lomeña, F., Molinuevo, J. L., Serradell, M., Salamero, M., Cot, A., Ros, D., Pavía, J., Santamaria, J., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70152-1 · Cited by 311
Postuma, R. B., Bertrand, J., Montplaisir, J., Desjardins, C., Vendette, M., Rios Romenets, S., Panisset, M., & Gagnon, J. (2012) · Movement Disorders · doi:10.1002/mds.24939 · Cited by 305
KUNZ, D., & MAHLBERG, R. (2010) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2010.00848.x · Cited by 269
Cited by
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Diagnosis and Treatment of Parkinson Disease: A Review
Armstrong, M. J., & Okun, M. S. (2020) · JAMA · doi:10.1001/jama.2019.22360 · Cited by 2,924
New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation
Zisapel, N. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14116 · Cited by 860
Walker, Z., Possin, K. L., Boeve, B. F., & Aarsland, D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00462-6 · Cited by 592
Koo, D. L., Lee, J. Y., & Nam, H. (2018) · Sleep Medicine · doi:10.1016/j.sleep.2018.05.042 · Cited by 8
Metadata
- Authors
- Howell, M. J., & Schenck, C. H.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2015-06-01
- Volume
- 72
- Issue
- 6
- Pages
- 707
- ISSN
- 2168-6149 (ISSN-L)
- OpenAlex
- W2145139478
- Cited by
- 261
- References
- 28
- FWCI
- 28.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease. https://app.cochat.ai/papers/10.1001/jamaneurol.2014.4563
- The paper
- Howell, M. J., & Schenck, C. H. (2015). Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2014.4563
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.